Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 1999
Cerebrospinal fluid measures of disease activity in patients with multiple sclerosisF Sellebjerg, M Christiansen, P M Nielsen, et al.
Acta Neurologica Scandinavica|March 5, 2003
Evidence favoring the involvement of CC chemokine receptor (CCR) 5 in T-lymphocyte accumulation in optic neuritisT L Sørensen, R M Ransohoff, J Jensen, et al.
Neurology|August 26, 1998
Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MSF Sellebjerg, J L Frederiksen, P M Nielsen, et al.
Neurology|May 5, 1999
A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritisF Sellebjerg, H S Nielsen, J L Frederiksen, et al.
Journal of Neuroimmunology|August 22, 2006
CD8+ T cell activation correlates with disease activity in clinically isolated syndromes and is regulated by interferon-beta treatmentJ Jensen, A R Langkilde, J L Frederiksen, et al.
Ugeskrift for Laeger|January 22, 2000
[Randomized controlled trial of high-dose peroral methylprednisolone in attacks of multiple sclerosis]F Sellebjerg, J L Frederiksen, P M Nielsen, et al.
Scandinavian Journal of Immunology|July 27, 2006
Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosisM Krakauer, P S Sorensen, M Khademi, et al.
Neurology|December 15, 2004
IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MSP Soelberg Sorensen, J Haas, F Sellebjerg, et al.
European Journal of Neurology|February 13, 2016
Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosisM Møllgaard, M Degn, F Sellebjerg, et al.
Pageof 10